Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price

Pharma results may benefit from rupee depreciation, particularly for exporters, though elevated freight and input costs remain risks. InCred sees potential pressure at Dr Reddy’s, Divi’s, Lupin, Cipla, Torrent Pharma and Blue Jet Healthcare in Q2FY27. Check its top stock picks in the segment.
Read the full story on Mint Opens livemint.com in a new tab
Advertisement
CallZenixAI Voice Bot, Dialer & IVR SolutionsCloud dialer and contact-center software for your teamKnow more
This is a short summary of a story published by Mint, shown with a link to the original. The full story, photo and reporting belong to Mint.











